From the Journals

Increased schizophrenia, affective disorder risks associated with infections


 

Increased risks of schizophrenia and affective disorders were found to be associated with infections treated with anti-infective agents and with infections requiring hospitalization, a large-scale study shows.

Researchers examined health records of all 1,015,447 individuals born in Denmark from 1985 to 2002, their history of treatment of infection, and the risk of schizophrenia and affective disorders.

Infections previously have been shown to be associated with increased risks of mental disorders. The goal of the current study was to investigate whether the use of anti-infective agents in primary care settings had a similar association.

And the researchers did find such an association: an increased risk of schizophrenia (hazard ratio, 1.37; 95% confidence interval, 1.2-1.57) and an increased risk of affective disorders (HR, 1.64; 95% CI, 1.48-1.82) associated with the use of anti-infective agents.

“The excess risk was primarily driven by infections treated with antibiotics, whereas infections treated with antivirals, antimycotics, and antiparasitic agents were not significant after mutual adjustment,” wrote Ole Köhler, MD, of Aarhus University Hospital, Risskov, Denmark, and his associates (Acta Psychiatr Scand. 2017 Feb;135[2]:97-105).

An even higher risk of schizophrenia and affective disorders was found to be associated with individuals with infections requiring hospitalization (HR, 2.05; 95% CI, 1.77-2.38; and HR, 2.59; 95% CI, 2.31-2.89; respectively). Find more details about the study here.

Recommended Reading

Give serious thought before starting antipsychotics in elders
MDedge Internal Medicine
Statement warns of drugs causing or exacerbating heart failure
MDedge Internal Medicine
Withdrawing risperidone spikes risk for psychotic relapse in hallucinating Alzheimer’s patients
MDedge Internal Medicine
Type 2 diabetes peer-led intervention in primary care tied to improved depression symptoms
MDedge Internal Medicine
FDA adds lurasidone contraindication to HIV drug labels
MDedge Internal Medicine
Psychiatric risks quantified in siblings of mental disorder patients
MDedge Internal Medicine
Experts offer tips on anxiety, depression, and psychosis in Parkinson’s
MDedge Internal Medicine
Cannabis use after first-episode psychosis may raise relapse risk
MDedge Internal Medicine
Recognizing anti-NMDA receptor encephalitis psychosis on the psych ward
MDedge Internal Medicine
Children with psychotic illness aren’t treated soon enough
MDedge Internal Medicine